Based on these previous findings, the present study investigated whether common genetic variants at both CYP17A1 and SERPINA6/A1 loci are associated with the metabolic syndrome, its related cardiometabolic risk factors, and circulating glucocorticoids, in black South Africans. This evidence concerns the gene CYP17A1 and metabolic syndrome.